Literature DB >> 24387706

Prevalence of drug resistance in human immunodeficiency virus type 1-infected treatment-naive children in Pune, India.

Mukesh Kumar1, Sourav Sen, Rakesh K Gupta, Devidas Chaturbhuj, Srikanth P Tripathy, Ramesh S Paranjape.   

Abstract

Abstract We report the presence of drug resistance mutations in 7.4% (2/27) of the treatment-naive, HIV-1-infected children in Pune, India, who had HIV-1 RNA levels >1,000 copies/ml. Nonnucleoside reverse transcriptase inhibitor (NNRTI) mutations, namely A98G and K103N, were observed in two separate sequences. In addition, three study sequences displayed three separate HIV-1 protease minor resistance mutations-L10I, A71T, and T74S. These preliminary data from Pune, India, reporting the presence of HIVDR in treatment-naive, HIV-1-infected children, reinforces the need to conduct large-scale studies to assess the prevalence of primary HIVDR in the pediatric population, which in turn will aid in planning protocols and policies related to antiretroviral treatment for the pediatric population.

Entities:  

Mesh:

Year:  2014        PMID: 24387706      PMCID: PMC3938931          DOI: 10.1089/AID.2013.0222

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  18 in total

1.  Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations.

Authors:  Alaka Deshpande; Patricia Recordon-Pinson; Ranjana Deshmukh; Muriel Faure; Valérie Jauvin; Isabelle Garrigue; Marie-Edith Lafon; Hervé J Fleury
Journal:  AIDS Res Hum Retroviruses       Date:  2004-09       Impact factor: 2.205

2.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

3.  Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.

Authors:  Deborah Persaud; Paul Palumbo; Carrie Ziemniak; Jie Chen; Stuart C Ray; Michael Hughes; Peter Havens; Murli Purswani; Aditya H Gaur; Ellen Gould Chadwick
Journal:  J Infect Dis       Date:  2007-04-05       Impact factor: 5.226

4.  Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

Authors:  Annemarie M J Wensing; David A van de Vijver; Gioacchino Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Maire-Laure Chaix; Dominique Costagliola; Andrea De Luca; Inge Derdelinckx; Zehava Grossman; Osamah Hamouda; Angelos Hatzakis; Robert Hemmer; Andy Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh MacRae; Irina Maljkovic; Carmen de Mendoza; Laurence Meyer; Claus Nielsen; Eline L Op de Coul; Vidar Ormaasen; Dimitris Paraskevis; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika Salminen; Jean-Claude Schmit; Francois Schneider; Rob Schuurman; Vincent Soriano; Grzegorz Stanczak; Maja Stanojevic; Anne-Mieke Vandamme; Kristel Van Laethem; Michela Violin; Karin Wilbe; Sabine Yerly; Maurizio Zazzi; Charles A Boucher
Journal:  J Infect Dis       Date:  2005-08-15       Impact factor: 5.226

5.  HIV-1 drug resistance in HIV-1-infected children in the United Kingdom from 1998 to 2004.

Authors:  Rana Chakraborty; Colette J Smith; David Dunn; Hannah Green; Trinh Duong; Katja Doerholt; Andrew Riordon; Hermione Lyall; Pat Tookey; Karina Butler; Caroline A Sabin; Di Gibb; Deenan Pillay
Journal:  Pediatr Infect Dis J       Date:  2008-05       Impact factor: 2.129

6.  Characterization of HIV-1 isolates from antiretroviral drug-naive children in southern India.

Authors:  Lakshmi Soundararajan; Ramesh Karunaianandham; Valerie Jauvin; Marie Helene Schrive; Ranjani Ramachandran; Paranji R Narayanan; Herve J Fleury; Soumya Swaminathan
Journal:  AIDS Res Hum Retroviruses       Date:  2007-09       Impact factor: 2.205

Review 7.  Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings.

Authors:  Renaud Becquet; Didier K Ekouevi; Elise Arrive; Jeffrey S A Stringer; Nicolas Meda; Marie-Laure Chaix; Jean-Marc Treluyer; Valériane Leroy; Christine Rouzioux; Stéphane Blanche; François Dabis
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

8.  Human immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral DNA among antiretroviral treatment-naive and treatment-experienced patients from Pune, India.

Authors:  Sourav Sen; Srikanth P Tripathy; Vaishali M Chimanpure; Ajit A Patil; Rajani D Bagul; Ramesh S Paranjape
Journal:  AIDS Res Hum Retroviruses       Date:  2007-04       Impact factor: 2.205

9.  Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study.

Authors:  Patricia Cane; Ian Chrystie; David Dunn; Barry Evans; Anna Maria Geretti; Hannah Green; Andrew Phillips; Deenan Pillay; Kholoud Porter; Anton Pozniak; Caroline Sabin; Erasmus Smit; Jonathan Weber; Mark Zuckerman
Journal:  BMJ       Date:  2005-11-18

10.  Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.

Authors:  Anitha Moorthy; Amita Gupta; Ramesh Bhosale; Srikanth Tripathy; Jayagowri Sastry; Smita Kulkarni; Madhuri Thakar; Renu Bharadwaj; Anju Kagal; Arvind V Bhore; Sandesh Patil; Vandana Kulkarni; Varadharajan Venkataramani; Usha Balasubramaniam; Nishi Suryavanshi; Carrie Ziemniak; Nikhil Gupte; Robert Bollinger; Deborah Persaud
Journal:  PLoS One       Date:  2009-01-01       Impact factor: 3.240

View more
  5 in total

1.  Antiretroviral Treatment and Resistance Patterns in HIV-Infected Children.

Authors:  Olatunji Adetokunboh; Oluyemi Atibioke; Tolulope Balogun; Mojisola Oluwasanu
Journal:  Curr Infect Dis Rep       Date:  2015-10       Impact factor: 3.725

2.  HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda.

Authors:  Cissy Kityo; Kim Catherina Eve Sigaloff; Tamara Sonia Boender; Elizabeth Kaudha; Joshua Kayiwa; Victor Musiime; Andrew Mukuye; Mary Kiconco; Immaculate Nankya; Llilian Nakatudde-Katumba; Job C J Calis; Tobias F Rinke de Wit; Peter N Mugyenyi
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02-11       Impact factor: 2.205

Review 3.  Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations.

Authors:  Samiran Panda; Soumya Swaminathan; Khurshid A Hyder; Eva-Maria Christophel; Razia N Pendse; Achuthan N Sreenivas; Setiwan J Laksono; Rahul Srivastava; Gopinath B Nair; Tjandra Y Aditama; Pratap Singhasivanon; Arun B Thapa; Swarup K Sarkar
Journal:  BMJ       Date:  2017-09-05

4.  Cost-effectiveness of a novel strategy of HIV/AIDS care in Armed Forces: A stochastic model with Monte Carlo simulation.

Authors:  S Shankar; Santosh Karade; Rajul K Gupta; M V Singh
Journal:  Med J Armed Forces India       Date:  2019-07-10

5.  Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.

Authors:  Catherine Godfrey; Marina Bobkova; Charles Boucher; Giovanni Ravasi; Ping Chen; Fujie Zhang; Yasong Wu; Rami Kantor
Journal:  J Infect Dis       Date:  2017-12-01       Impact factor: 7.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.